Prevalence and Environmental Correlates of Small Airways Dysfunction in a Rural Swiss Cohort

Asthma

Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study

Lancet Respir Med

Galant SP, Kuks PJM, Kole TM, Kraft M, Siddiqui S, Fabbri LM, Beghé B, Rabe KF, Papi A, Brightling CE, Singh D, Kocks JWH, Franzini L, Vonk JM, Kerstjens HAM, Heijink IH, Pouwels SD, Slebos DJ, van den Berge M

doi: 10.1016/S2213-2600(25)00283-8

RECOMMENDED

Asthma

A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Respir Med

Menzella F, Cottini M, Lombardi C, Senna G, Chan R, Bosi A, Bortoli M, Tonin S, Corsi L, Rastelli A, Marchi MR

doi: 10.1016/j.rmed.2025.108054

Tuberculosis

Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study

J Acquir Immune Defic Syndr

Hilfiker A, Schoepf IC, Avery EF, Ledergerber B, Colin-Benoit E, Riebensahm C, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Marinosci A, Günthard HF, Kouyos R, Nemeth J, Tarr PE, Swiss HIV Cohort Study

doi: 10.1097/QAI.0000000000003714

RECOMMENDED

COPDEmphysema

Distinct Morphological Types of Small Airway Obstructions in Smokers with Emphysema and End-Stage COPD

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Am J Respir Crit Care Med

Geudens V, De Fays C, Willems L, Vermaut A, Aerts G, Kerckhof P, Kaes J, Hooft C, Jin X, Beeckmans H, Mohamady Y, Aversa L, Goos T, Vermant M, Gyselinck I, Verhaegen J, Van Slambrouck J, Aelbrecht C, Higham A, Coudyzer W, Cortesi EE, Vanstapel A, McDonough JE, Carlon MS, Quarck R, Boone MN, Dupont LJ, Weynand B, Pilette C, Everaerts S, Van Raemdonck DE, Ceulemans LJ, Hogg JC, Hackett TL, Vos R, Wuyts WA, Janssens W, Jacob J, Vanaudenaerde BM, Gayan-Ramirez G

doi: 10.1164/rccm.202410-2101OC

Asthma

Small Airways Disease as a Novel Target for Mepolizumab in Asthma-The SASAM Prospective Real-Life Study

J Clin Med

Bonini M, Boccabella C, Cefaloni F, De Corso E, Donfrancesco F, Schiavi E, Richeldi L

doi: 10.3390/jcm14092928

RECOMMENDED

Lung Cancer

Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients

★ 2 Recommended by Dr Martin Frey, Faculty Member

Clin Lung Cancer

Barrichello APC, Elkrief A, Ricciuti B, Ganta T, Marron TU, Wang X, Lotter W, Lindsay J, Santo V, Cortellini A, Sharma B, Felt K, Pfaff K, Lamberti G, Pecci F, Federico AD, Makarem M, Gandhi MM, Nguyen T, Haradon D, Vaz VR, Johnson BE, Debnath N, Wang Y, Kuang AG, Saeed A, Radford M, Lovly CM, Nebhan CA, Pinato DJ, Rodig SJ, Schoenfeld AJ, Awad MM, Alessi JV, Naqash AR

doi: 10.1016/j.cllc.2025.01.014

RECOMMENDED

Lung Cancer

Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lung Cancer

Liu G, Abrahami D, Ramachandran P, Messina R, Rifi N, Yang H, Chai X, Li B, Ramaswamy K, Iyengar P, Pennell NA, Shaw AT

doi: 10.1016/j.lungcan.2025.108858

Further Publications

Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases

Respir Med Case Rep

Takigawa Y, Sato K, Minami D, Kudo K, Matsumoto S, Fujiwara M, Ichikawa T, Inoue T, Matsuoka S, Watanabe H, Sato A, Shoda H, Ishikawa N, Fujiwara K, Shibayama T

doi: 10.1016/j.rmcr.2025.102217

RECOMMENDED

Lung Cancer

Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

ESMO Open

Peters S, Salomonsen RJ, Diaz Perez I, Shcherbakova T, Wang A, Cai L, Sadow S, Liu SV

doi: 10.1016/j.esmoop.2025.106031

Related content

Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational study

A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction

Mycobacterium tuberculosis Infection and Acute or Subclinical Coronary Artery Disease: the Swiss HIV Cohort Study

Distinct Morphological Types of Small Airway Obstructions in Smokers with Emphysema and End-Stage COPD

Small Airways Disease as a Novel Target for Mepolizumab in Asthma-The SASAM Prospective Real-Life Study

Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients

Real-world incidence, prevalence, and clinical impact of brain metastases in patients with ALK-positive metastatic non-small cell lung cancer treated with first-line ALK tyrosine kinase inhibitors

Successful stent removal after chemoradiotherapy followed by durvalumab for locally advanced non-small cell lung cancer with airway stenosis: A report of three cases

Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study